Exciting News! President Joe Biden signed a groundbreaking Executive Order on March 18, 2024, expanding the White House Initiative on Women’s Health Research. This initiative marks a significant step towards addressing women’s health issues through enhanced funding, research, and collaboration. Notably, a $12 billion investment proposal for the NIH has been introduced to establish a…

Read article →

The future of Antibody-Drug Conjugates (ADCs) in drug development is promising and dynamic, with numerous exciting prospects on the horizon. Over 100 ADCs are currently under preclinical and early-stage clinical research, highlighting the significant investment in advancing this therapeutic class. Researchers are shifting their focus from targeting oncogenic driver mutations to exploring antigens that are…

Read article →